1271 - 1280 of 7877 Results
Title
Year
- Recruitment and Retention in Remote Research: Learnings From a Large, Decentralized Real-world Study2022OPENTitle: Recruitment and Retention in Remote Research: Learnings From a Large, Decentralized Real-world StudyJournal Name: JMIR Formative ResearchPublisher: JMIR Publications Inc.Vol: 6Issue #: 11Start Page: e40765End Page: e40765Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/40765Best OA location URL: https://jmir.org/api/download?alt_name=formative_v6i11e40765_app1.pdf&filename=cda272c3b0860a3c3018580d7ddb36f6.pdfCitation Count: 8
- Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI2022RESTRICTEDTitle: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSIJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288Citation Count: 7
- Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study2022RESTRICTEDTitle: Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort StudyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201468Citation Count: 6
- Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicine2022RESTRICTEDTitle: Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicineJournal Name: Frontiers in Molecular MedicinePublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmmed.2022.933383Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmmed.2022.933383/pdfCitation Count: 0
- Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study2022OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://doi.org/10.1177/13524585221125381Citation Count: 18
-
OPENTitle: 147th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: S29Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26484Citation Count: 22
-
OPENTitle: 33RD International Symposium on the Autonomic Nervous SystemJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 32Issue #: 5Start Page: 313End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00892-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-022-00892-z.pdfCitation Count: 1
-
OPENTitle: Atypical antipsychotic use and mortality risk in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 103Issue #:Start Page: 17End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013Best OA location URL: http://manuscript.elsevier.com/S1353802022002693/pdf/S1353802022002693.pdfCitation Count: 5
- Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities2022OPENTitle: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activitiesJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 184Issue #:Start Page: 106409End Page: 106409Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409Best OA location URL: http://manuscript.elsevier.com/S1043661822003541/pdf/S1043661822003541.pdfCitation Count: 9
-
RESTRICTEDTitle: Delivery of RNA Therapeutics: The Great Endosomal Escape!Journal Name: Nucleic Acid TherapeuticsPublisher: Mary Ann Liebert IncVol: 32Issue #: 5Start Page: 361End Page: 368Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/nat.2022.0004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595607Citation Count: 44